Biotech

All Articles

A deeper examine Strong Biotech's Strong 15

.In this week's incident of "The Top Line," our experts're diving in to Fierce Biotech's yearly Toug...

Lilly faces stage 2 failure of tau-targeting med

.The confetti is still soaring coming from Eli Lilly's gathering celebrating the commendation of Alz...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our roundup of substantial management hirings, shootings and...

Lykos will certainly ask FDA to reassess its own decision adhering to denial of MDMA treatment for post-traumatic stress disorder

.Observing an unsatisfactory showing for Lykos Rehabs' MDMA candidate for post-traumatic stress diso...

AN 2 fifty percents census, stops period 3 trial after data dissatisfy

.AN2 Therapies is reconsidering its own service in feedback to poor midphase information, swearing t...

Merck pays for $700M for bispecific, snooping autoimmune position and possibility to challenge Amgen in cancer cells

.Merck &amp Co. is paying for $700 million ahead of time to challenge Amgen in a blood cancer market...

Gilead spends J&ampJ $320M to exit licensing package for seladelpar

.With Gilead Sciences about to an FDA decision for its own liver condition medicine seladelpar, the ...

' All hands on deck' at Lilly as peers target excessive weight market

.Chief executive officer David Ricks may see the providers putting together outdoors tents at baseca...

Entero giving up team, vacating workplace and also stopping briefly R&ampD

.Cushion Liquidators has actually transformed Entero Therapeutics white as a sheet. The collector go...

Exelixis loses ADC after deciding it's no match for Tivdak

.Exelixis is actually giving up on its own tissue variable (TF)- targeting antibody-drug conjugate a...